Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 2226 participants.

Also called NCT02290028

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 2,226 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02290028
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Denmark, Germany, Hungary, Israel, Italy, Slovakia, Spain, Switzerland (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02290028. Allocation not applicable; no masking; primary purpose other. Start 2014-12-16 (actual); primary completion 2020-01-23 (actual). Results posted on 2021-03-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads
Acronym
QP ExCELs
Condition
Heart Failure
Intervention (Device)
Sentus QP left ventricular lead
Lead sponsor
Biotronik SE & Co. KG (class: industry)
Collaborator
Biotronik, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02290028
Content hash
48cf4a2cda2444472526cc3e3d4986ecae9caa85044cbd2d81effd770c271290